ArticleFrontiers in medicine2026
Real-world experience of Dolutegravir/Lamivudine for rapid initiation of antiretroviral therapy among treatment-naïve HIV-1-infected adults in China: a multicenter retrospective study.
Aixin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.